Sagility Reports Q1 Net Profit Rises to ₹217 Crore, Revenue Up at ₹1,963 Crore
Sagility's Q1 FY27 results highlight a 27.55% YoY increase in revenue to ₹1,963 crore and a 45.64% YoY increase in net profit to ₹217 crore. The EBITDA margin expanded significantly to 22.32%, driven by strong operational execution and strategic expansions, including the acquisition of CareSeed.
Market snapshot: Sagility Limited has announced its financial results for Q1 FY27, showcasing strong top-line and bottom-line growth. Revenue rose to ₹1,963 crore, while consolidated net profit grew to ₹217 crore, driven by robust client demand in the U.S. healthcare outsourcing market and significant operational margin expansion.
Data Snapshot
- Revenue from Operations reached ₹1,963 crore, indicating strong organic growth.
- EBITDA stood at ₹440 crore, representing improved operational performance.
- EBITDA Margin expanded significantly to 22.32%.
- Consolidated Net Profit rose to ₹217 crore.
What's Changed
- Q1 Revenue increased ≈27.55% YoY (derived: ₹1,963 cr vs ₹1,539 cr).
- Q1 Consolidated Net Profit jumped ≈45.64% YoY (derived: ₹217 cr vs ₹149 cr).
- Q1 EBITDA grew ≈54.93% YoY (derived: ₹440 cr vs ₹284 cr).
- EBITDA Margin expanded by 385 basis points YoY to 22.32% from 18.47%.
Key Takeaways
- Sagility achieved double-digit growth across revenue, EBITDA, and net profit.
- The 385 bps margin expansion highlights strong operational leverage and billing efficiencies.
- Strategic acquisition of CareSeed and robust client additions have expanded Sagility's service portfolio.
- Steady contract wins, including $35.3 million in new Annual Contract Value, reinforce near-term growth visibility.
SAHI Perspective
Sagility's Q1 FY27 performance reflects a robust expansion phase, driven by strong healthcare outsourcing demand in the U.S. market. The sharp expansion in EBITDA margins demonstrates that the company is successfully offsetting global talent costs through automated workflows and operational scale. The acquisition of CareSeed and continuous client wins signal that Sagility is rapidly gaining market share as U.S. healthcare payers face intense cost pressures and seek specialized BPO solutions.
Market Implications
The results are likely to be viewed positively by the street, potentially supporting the stock price which has seen steady consolidation. The combination of strong revenue growth and margin expansion positions Sagility as a resilient player in the IT-enabled services space. Given its focus on the high-margin U.S. healthcare sector, the company stands out compared to generic IT services companies facing growth headwinds.
Trading Signals
Market Bias: Bullish
Sagility demonstrated robust financial performance in Q1 FY27, with revenue growing 27.55% YoY to ₹1,963 crore and net profit expanding 45.64% YoY to ₹217 crore. The significant expansion in EBITDA margin to 22.32% reflects strong operational efficiency, supported by client additions and recent strategic acquisitions like CareSeed.
Overweight: Healthcare IT, BPO Services
Trigger Factors:
- Integration progress of CareSeed
- Sustained revenue momentum in the US healthcare market
- Ability to manage voluntary attrition rates
Time Horizon: Medium-term (3-12 months)
Industry Context
The U.S. healthcare outsourcing industry is undergoing rapid tech-led transformation as payers and providers seek cost optimization in response to regulatory changes and medical utilization pressures. Sagility is positioned to capitalize on this multi-billion dollar addressable market, utilizing artificial intelligence and platforms like SmarTec and Synchrony to improve member and patient outcomes while keeping operational costs low.
Key Risks to Watch
- Concentration Risk: High reliance on the U.S. healthcare payer market, making it sensitive to regulatory shifts or policy changes in the U.S.
- Attrition and Talent Retention: Managing voluntary attrition in a highly competitive global service delivery market.
- Integration Risks: Smooth operational integration of newly acquired entities like CareSeed.
Recent Developments
Sagility acquired U.S.-based healthcare analytics company CareSeed on June 11, 2026, to expand its healthcare quality and HEDIS reporting capabilities. Additionally, the board recommended a final dividend of ₹0.10 per share for the financial year ended March 31, 2026, with the record date set as August 7, 2026, and the AGM scheduled for August 20, 2026.
Closing Insight
With a solid double-digit top-line growth and substantial margin improvement, Sagility is proving its capability to translate specialized domain expertise into strong financial outcomes. Strategic client acquisitions and targeted inorganic growth will be key drivers of long-term value.
High Performance Trading with SAHI.
Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.
Open Free AccountRelated
JSW Holdings Reports Q2 Consolidated Net Profit of ₹1.3 Billion Versus ₹672 Million YoY
Hemisphere Properties Obtains ₹160.125 Crore Initial Payment For ₹640.50 Crore Land Sale
Lincoln Pharmaceuticals Reports Q2 Standalone Net Profit of ₹20.4 Crore vs ₹20 Crore YoY
Pidilite Industries Expects Stronger H2 Margins Near 24% Guidance Upper Bound
Recent
JSW Holdings Reports Q2 Consolidated Net Profit of ₹1.3 Billion Versus ₹672 Million YoY
Hemisphere Properties Obtains ₹160.125 Crore Initial Payment For ₹640.50 Crore Land Sale
Lincoln Pharmaceuticals Reports Q2 Standalone Net Profit of ₹20.4 Crore vs ₹20 Crore YoY
Pidilite Industries Expects Stronger H2 Margins Near 24% Guidance Upper Bound
GK Energy Reports Growth in Q2 Consolidated Net Profit YoY
Frequently Asked Questions (FAQs)
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.